AU2020349671A1 — Compositions for use in inhibiting Src kinase and treating and preventing associated disorders
Assigned to Enzene Biosciences Ltd · Expires 2022-03-31 · 4y expired
What this patent protects
The present invention encompasses compounds and composition that inhibit Src kinase and methods of treating or preventing disorders associated therewith. In some embodiments, the invention encompasses compositions and combinations of agents that act synergistically inhibit the gr…
USPTO Abstract
The present invention encompasses compounds and composition that inhibit Src kinase and methods of treating or preventing disorders associated therewith. In some embodiments, the invention encompasses compositions and combinations of agents that act synergistically inhibit the growth of cancer cells and particularly the compositions and combinations can be used for the treatment of cancer.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.